Prospective Comparative Evaluation of Stone Clearance and Complications in Renal Stones Measuring 2 to 3.5 Centimeters: Percutaneous Nephrolithotomy (PCNL) versus Retrograde Intrarenal Surgery (RIRS)

前瞻性比较评价直径 2 至 3.5 厘米肾结石的清除率和并发症:经皮肾镜取石术 (PCNL) 与逆行肾内手术 (RIRS)

阅读:1

Abstract

Background Percutaneous nephrolithotomy (PCNL) and retrograde intrarenal surgery (RIRS) are the two most commonly used minimally invasive surgical techniques for renal stone disease, which is a major worldwide health burden. Because it is less intrusive, RIRS has become more common even though PCNL is still the gold standard for big renal stones. Clinical decision-making regarding the best intervention requires the use of comparative evidence. Objective To evaluate the perioperative results and stone-free rates of PCNL and RIRS in patients with kidney stones. Methodology In this prospective randomized controlled trial, patients with kidney stones (2-3.5 cm; n=440) were split evenly between two groups: PCNL (n=220) and RIRS (n=220). The following outcomes were evaluated: perioperative problems, hospital stay, operation time, stone-free rate, and auxiliary procedures. Independent t-tests for continuous variables and chi-square tests for categorical variables were used in the statistical analysis; p<0.05 was deemed significant. Results The PCNL group had a significantly higher stone-free rate than the RIRS group (90.0% vs. 80.0%, χ²=8.57, p=0.003). The mean operative time was longer in the PCNL group compared to RIRS (92.4 ± 18.5 vs. 78.6 ± 15.3 min, t=8.42, p<0.001). The mean hospital stay was also longer for PCNL (3.6 ± 1.2 vs. 1.8 ± 0.7 days, t=18.7, p<0.001). Patients undergoing PCNL experienced greater intraoperative bleeding (17.3% vs. 2.7%, χ²=26.9, p<0.001) and a higher mean hemoglobin drop (1.6 ± 0.8 vs. 0.7 ± 0.5 g/dl, t=13.1, p<0.001). Auxiliary procedure rates were higher in the RIRS group (20.0% vs. 10.0%, χ²=8.57, p=0.003). Conclusion Although PCNL provides better stone removal than RIRS, it is linked to longer operating times, longer hospital stays, and higher incidence of complications. Individualized treatment should be chosen according to the patient's and the stone's characteristics.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。